Sign up
Tech Capital

Small-Cap Snapshot: Restoration Robotics to offer a master class on robot-assisted hair restoration

The ARTAS Robotic Hair Restoration System uses robots to help physicians with hair transplants
The medical device company trades under the ticker "HAIR"

Medical device company Restoration Robotics Inc (NASDAQ:HAIR) is offering an education master class to train physicians on how to use its hair restoration technology. Led by Dr. Robert Bernstein of the Bernstein Medical Center for Hair Restoration, the class series will feature hands-on training including a segment on hairline design. Trading under the ticker “HAIR”, the company develops the ARTAS Robotic Hair Restoration System, which uses robots to assist physicians with the procedure. Shares of the California-based company were up nearly 5% to US$3.05.

scPharamaceuticals Inc (NASDAQ:SCPH) shares sunk after the U.S. Food and Drug Administration rejected its application for its drug Furoscix. The drug is intended to treat fluid overload in heart failure patients, also known as an edema. The biopharma received a complete response letter from the FDA, asking for additional human factor studies as well as device modifications. A clinical validation study may also be necessary. Shares of the clinical-stage pharma company fell more than 20% to US$5.86.

READ: Shares of Korn/Ferry International soar after 4Q earnings beat Street on strong revenue

vTv Therapeutics Inc (NASDAQ:VTVT) released the topline results for its drug azeliragon, failing to meet the co-primary endpoints. The drug is being developed to treat patients with mild Alzheimer’s disease but has yet to show significant enough improvements versus the placebo. The company plans to meet with the FDA to discuss the next steps toward approval. Shares of the biopharma were down more than 10% to US$1.70.

Talent agency Korn/Ferry International (NYSE:KFY) shares soared after crushing Wall Street estimates and offering a positive outlook for the year ahead. The company reported fourth-quarter earnings of US$0.80 on revenue of US$488.4mln versus analysts estimates of US$0.70 EPS on revenue of US$454.4mln. For the first quarter, the company forecast earnings between US$0.67 and US$0.75 per share on revenue between US$450mln and US$470mln, once again beating consensus estimates of US$0.66 EPS on revenue of US$432.8mln. Shares of the Los Angeles-based agency jumped more than 15% to US$65.39.

The small-cap indices were in slight decline with both the Russell 2000 and the S&P 600 seeing minimal losses.

Register here to be notified of future HAIR Company articles
View full HAIR profile View Profile
View All

Related Articles

© tech Capital 2019

Tech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed tech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Tech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Technology market.